Nebivololo E Idroclorotiazide Doc Generici (Hydrochlorothiazide, Nebivolol)

Nebivolol/Hydrochlorothiazide is indicated for the management of hypertension, a condition characterized by elevated arterial pressure.

• Hypertension: lowers systolic and diastolic blood pressure and reduces cardiovascular risk.
• Primary (essential) hypertension: provides effective control when monotherapy is insufficient.
• Combination therapy in adults: offers a convenient single‑tablet option for patients requiring both a beta blocker and a thiazide diuretic.

• Nebivolol selectively blocks β1‑adrenergic receptors, reducing heart rate and contractility, while also enhancing nitric‑oxide release for vasodilation. Hydrochlorothiazide inhibits NaCl reabsorption in the distal convoluted tubule, promoting natriuresis and diuresis, which together decrease plasma volume and peripheral resistance, resulting in lowered blood pressure.

Adverse reactions may vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate pain often transient.
• Dizziness: sensation of light‑headedness, especially on standing.
• Fatigue: generalized tiredness.
• Cough: dry or productive.
• Nausea: mild stomach upset.
• Increased urination: due to diuretic action.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure requiring medical attention.
• Electrolyte imbalance: notably low potassium or sodium levels.
• Gout flare: increased uric acid leading to joint pain.
• Pancreatitis: abdominal pain with elevated enzymes.
• Allergic reactions: rash, itching, or swelling.
• Renal impairment: reduced kidney function.

Patients should be evaluated for specific risk factors before initiating therapy.

• Monitor blood pressure: ensure target levels are achieved without excessive drop.
• Assess electrolytes: check potassium and sodium regularly.
• Evaluate renal function: baseline and periodic creatinine measurements.
• Use caution in diabetes: diuretics may affect glucose control.
• Avoid abrupt discontinuation: taper to prevent rebound hypertension.
• Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nebivolol/Hydrochlorothiazide may interact with several drug classes.

Major Interactions (Avoid)

• Other antihypertensives: risk of additive hypotension.
• Potassium‑sparing diuretics: may cause hyperkalemia.
• NSAIDs: can diminish diuretic efficacy and affect renal function.
• Lithium: increased lithium levels and toxicity.
• CYP2D6 inhibitors: elevate nebivolol concentrations.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: monitor renal function and potassium.
• Additional beta blockers: risk of excessive β‑blockade.
• Corticosteroids: may counteract antihypertensive effect.
• Antidiabetic agents: monitor glucose as diuretics may raise blood sugar.
• Antidepressants (tricyclics): potential additive cardiac effects.